LUNG FUNCTION AND ASTHMA CONTROL IN PATIENTS ON MEDIUM-TO-HIGH-DOSE ICS-LABA: A SYSTEMATIC REVIEW OF THE OBSERVATIONAL LITERATURE

被引：0
|
作者：
Czira, A. [1 ]
Meeraus, W. [1 ]
Martin, A. [2 ]
Turner, M. [2 ]
Birch, H. [1 ]
Zhang, S. [3 ]
机构：
[1] GlaxoSmithKline, R&D Global Med, Brentford, England
[2] Evidera, Evidence Synth, Modeling & Commun, Waltham, MA USA
[3] GlaxoSmithKline, R&D Global Med, Collegeville, PA USA
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRS64
引用
收藏
页码：S729 / S729
页数：1
相关论文
共 50 条
  • [41] Effect of omalizumab on glucocorticoid use, lung function and asthma control in the treatment of allergic bronchopulmonary aspergillosis: a systematic review and meta-analysis
    Douglass, J.
    Jin, M.
    Elborn, J. S.
    Agarwal, R.
    Calhoun, Wj
    Jaumont, X.
    Lazarewicz, S.
    Yan, M.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [42] Late Breaking Abstract- Depemokimab efficacy/safety in patients with asthma on medium/high-dose ICS: The Phase IIIA randomised SWIFT-1/2 studies
    Jackson, David J.
    Wechsler, Michael E.
    Jackson, Daniel J.
    Korn, Stephanie
    Bernstein, David
    Pfeffer, Paul E.
    Martinez, Gustavo De Luiz
    Chen, Ruchong
    Saito, Junpei
    Jacques, Loretta
    Bird, Nicholas
    Schalkwijk, Stein
    Smith, Douglas
    Pavord, Ian D.
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [43] Efficacy and Safety of a Fixed Combination Extrafine Beclomethasone Dipropionate, Formoterol Fumarate, and Glycopyrronium Bromide (BDP/FF/GB) pMDI Treatment Compared to Fixed Combination BDP/FF in Patients with Uncontrolled Asthma on Medium Dose ICS/LABA: The TRIMARAN Study
    Paggiaro, P.
    Kuna, P.
    Kots, M.
    Corre, S.
    Carzana, E.
    Vele, A.
    Georges, G.
    Petruzzelli, S.
    Virchow, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [44] The Combination of Indacaterol/Glycopyrronium/Mometasone Furoate Is Superior to High-Dose Salmeterol/Fluticasone Propionate in Improving Lung Function in Patients with Asthma
    Watz, H.
    Hohlfeld, J. M.
    Singh, D.
    Beier, J.
    Scholz, V.
    Diamant, Z.
    Liu, J.
    Hua, S.
    Pinot, P.
    Jones, I.
    Sarkar, A.
    Tillmann, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [45] Prevalence, Treatment, and Control of Hypercholesterolemia in High Cardiovascular Risk Patients: Evidences from a Systematic Literature Review in Spain
    Alex de la Sierra
    Xavier Pintó
    Carlos Guijarro
    José López Miranda
    Daniel Callejo
    Jesús Cuervo
    Rudi Subirà
    Marta Rubio
    Advances in Therapy, 2015, 32 : 944 - 961
  • [46] Prevalence, Treatment, and Control of Hypercholesterolemia in High Cardiovascular Risk Patients: Evidences from a Systematic Literature Review in Spain
    de la Sierra, Alex
    Pinto, Xavier
    Guijarro, Carlos
    Lopez Miranda, Jose
    Callejo, Daniel
    Cuervo, Jesus
    Subira, Rudi
    Rubio, Marta
    ADVANCES IN THERAPY, 2015, 32 (10) : 944 - 961
  • [47] Safety and Tolerability of Medium and High Doses of Mometasone Furoate/Formoterol (MF/F) Combination Treatment, Administered Via a Metered-Dose Inhaler (MDI), in Severe Asthma Patients Previously Treated with High-Dose Inhaled Corticosteroids (ICS).
    Weinstein, S. F.
    White, M.
    Corren, J.
    Nolte, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [48] Rate of Adverse Effects of Medium- to High-Dose Glucocorticoid Therapy in Systemic Lupus Erythematosus: A Systematic Review of Randomized Control Trials
    Savino Sciascia
    Elisa Mompean
    Massimo Radin
    Dario Roccatello
    Maria J. Cuadrado
    Clinical Drug Investigation, 2017, 37 : 519 - 524
  • [49] Dupilumab reduces risk of severe exacerbations and improves FEV1 in patients on both high- and medium dose ICS with uncontrolled, moderate-to-severe asthma from the phase 3 LIBERTY ASTHMA QUEST Study
    Pavord, I
    Papi, A.
    Wenzel, S.
    Park, H.
    Zhang, B.
    Staudinger, H.
    Maroni, J.
    Rowe, P.
    Amin, N.
    Pirozzi, G.
    Ruddy, M.
    Akinlade, B.
    Graham, N. M. H.
    Teper, A.
    ALLERGY, 2018, 73 : 463 - 464
  • [50] Rate of Adverse Effects of Medium- to High-Dose Glucocorticoid Therapy in Systemic Lupus Erythematosus: A Systematic Review of Randomized Control Trials
    Sciascia, Savino
    Mompean, Elisa
    Radin, Massimo
    Roccatello, Dario
    Cuadrado, Maria J.
    CLINICAL DRUG INVESTIGATION, 2017, 37 (06) : 519 - 524
12345